Cellectar Biosciences Inc (CLRB)

[Crusader]

NEWS: 40% ORR


VERY GOOD NEWS:


https://seekingalpha.com/news/3612538-cellectars-lead-asset-shows-40-orr-in-heavily-pre-treated-mm-patients-in-mid-stage-study?utm_medium=email&utm_source=seeking_alpha&mail_subject=clrb-cellectar-s-lead-asset-shows-40-orr-in-heavily-pre-treated-mm-patients-in-mid-stage-study&utm_campaign=rta-stock-news&utm_content=link-1

[Sluicebox]

Cellectar can beat that ! Belantamab just approved for R/R MM with 4 prior lines of therapy including immunomodulatory drug (IMiD), a proteasome inhibitor, and an anti-CD38 antibody, with ORR/PFS which I believe CLR-131 will match and with a much better AE profile.
Top sales estimate 2026 $1,5B based on current indications/trials, but a lot of new indications could be added down the line for Belantamab.

[Sluicebox]

Looking very much forward to their pediatric neuro oncology data in December.

https://investor.cellectar.com/press-releases/detail/245/cellectar-announces-poster-presentation-at-the

[Sluicebox]

Too easy to manipulate, and too many short term investors.

[Sunofwolf]

suk you in then thing falls like a meteor-LOL!

[Pennybuster]

Nice Day Heading Higher.

[Sunofwolf]

some worthless news, to get people to buy a little while every time goes nowhere. Insiders always dump on news.

[daddydo]

Great volume premarket on cancer news
Should see nice pop on open
Can we get a new 52 week high?

[Pennybuster]

On Radar!

[Sluicebox]

Some highlight from the paragraph about CLR-131.
CLR-131 exploit the altered lipid composition of cancer cell membranes to more actively target tumors and deliver the radioactive payload into the cancer cell.
Advantages of this system include the PDCs’ ability to gain entry into a wide variety of cancer types and indiscriminately target all cells within a tumor without relying on expression of a specific antigen.
Furthermore, this technology could offer considerable flexibility in the types of payloads that can be used.
Cellectar has several other PDCs in preclinical development.
CLR 131 could be the first of many such drugs from Cellectar, with other payloads being explored.

[Sluicebox]

That doesn't make Cellectar a fraud just bad management in your view. But the oncology society seems to think CLR-131 is pretty fantastic. This is a great article explaining what CLR-131 (PDCs) is about. But I suspect you already know.
https://www.onclive.com/view/clr-131-leads-a-new-generation-of-lipid-based-cancer-drug-delivery-systems

[Sluicebox]

That doesn't make Cellectar a fraud just bad management in your view. But the oncology society seems to think CLR-131 is pretty fantastic. This is a great article explaining what CLR-131 (PDCs) is about. But I suspect you already know.
https://www.onclive.com/view/clr-131-leads-a-new-generation-of-lipid-based-cancer-drug-delivery-systems

[Sunofwolf]

Why I know this company is a fraud. The thing this company ever made that made money came from investors. The CEO covers up spending tons of money for his own fancy office in NJ. It has farmed out all its drug making to a unreliable company in Canada that none else really does business with. Only puts out news when insiders have stock they want to sell that they got for free. None can understand what they are actually doing-which is nothing but stealing money from investors.

[Sunofwolf]

Pt Barnum had a famous quote- (a sucker is born every Minute] LOL!

[Sluicebox]

European patent granted !! Loading up shares.

https://data.epo.org/publication-server/pdf-document?pn=3229810&ki=B1&cc=EP

[Sluicebox]

Great news, god to see them making some noice about their fantastic results. No company has ever had 100% ORR im LPL/WM nor a CR in mono therapy except for Cellectar !!

https://finance.yahoo.com/news/cellectar-announces-poster-presentation-clinical-120010247.html

[Sluicebox]

Why do you think this company is a scam ?

[Sunofwolf]

company is a scam, nothing here butt losers.

[Sluicebox]

Yes there is a big chance that CLR131 can be monetized in real life. Considering the huge potential compared with a crazy low Mcap, I consider this a value investment

[Sluicebox]

Yes there is a big chance that CLR131 can be monetized in real life. Considering the huge potential compared with a crazy low Mcap, I consider this a value investment

[Crusader]

What’s up here, traders?

CLRBZ (warrants) are up over 50% today on the heaviest volume in months for those warrants @ .17?

Why accumulate this POS? Unless, ....Naaaaa...CLR131 can be monetized for doing good in the real world for very sick MM patients!!!

[Crusader]

What’s up here, traders?

CLRBZ (warrants) are up over 50% today on the heaviest volume in months for those warrants @ .17?

Why accumulate this POS? Unless, ....Naaaaa...CLR131 can be monetized for doing good in the real world for very sick MM patients!!!

[Sluicebox]

Ups you'r right.

[Rymankoly]

He got free options (not a buy):
https://ih.advfn.com/stock-market/NASDAQ/cellectar-biosciences-CLRB/stock-news/82796093/statement-of-changes-in-beneficial-ownership-4

[Sluicebox]

VP CMO buys 100000 shares at 1.34. I will be buying on any dip and look forward to impressive PH II data readout shortly. This readout will confirm earlier efficacy and ignite road to quick aproval, with the orphans drug status. I los look forward to a $100 M priority voucher which is 4 x Mcap :-o

[Sluicebox]

New PT from Oppenheimer $5 outperform

[Sluicebox]

It's a real shame about the watering out of shareholders during the last many year, happy I was not part of that. And the mgm might not be the best.

But it doesn't change the fact that CLR-131 is a very interesting candidate with some very exiting trial results.
Just revisited their lates clinical presentation and think it is good news all around.
Just the fact that the MOA of CLR-131 is unique makes it relevant in later lines.


I look forward to the Clover-1 trial that will hopefully readout beginning of Q3. Strongly believe that the 2-cycle dosing will show solid results.

Also looking forward to update on phase I Pediatric Brain & Solid Tumors.

[Sunofwolf]

correct its only purpose is to pay for a fancy office in NJ for a Fat CEO who has done nothing but lose money for investors.-has zero income except for the fools that buy this garbage. Anything the company puts out is rubbish

[Jonnyo07]

Cellectar is garbage!

[stockguard]

7:44 am ET June 23, 2020
Cellectar Biosciences started at buy with $3 stock price target at Maxim Group

Maxim analyst Jason McCarthy initiated coverage of Cellectar Biosciences with a Buy rating and $3 price target. The analyst says the data in the company's development of phospholipid drug conjugates to target cancer's "addiction" to phospholipids have been "compelling". McCarthy further notes additional catalysts expected in the second half of 2020 and in 2021, with "updates on a pediatric study in solid tumors and r/r blood cancers", adding that Cellectar should also have cash runway well into 2021

[Sluicebox]

Finally - money on the book to drive forward with CLR131, which looks very promising. Looking forward to update on two-cycle dosing cohort. Cheap and effective especially in the later lines where there are no alternatives for R/R MM R/R NHL having failed on tripple and quadruple combi and almost everything we can throw at these patients. Worth a listen https://viavid.webcasts.com/viewer/event.jsp?ei=1278219&tp_key=119af7bc64

[S3lfMade]

Company selling shares, most likely.

Most bios are in nonstop dilution mode.

[cash_cow1]

Why did it take a nose dive on opening bell. The News was great and it just skirted right off the road into a ditch. lol !

[S3lfMade]

CLR 131 is a radiotherapy designed to directly target cancer cells and limit exposure to healthy cells, unlike traditional treatment options.

[Crusader]

$5 Clover study of CLR131?

SonofGun!

[TTIME]

$CLRB , Great News !!

[Bula Vinaka]

How do you get in all this big plays before it happens SM?

[crudeoil24]

LOL. Your present today is an algo G&T.

[TheFinalCD]

Cellectar Receives FDA Fast Track Designation for CLR 131 in Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia



https://www.globenewswire.com/news-release/2020/05/26/2038539/0/en/Cellectar-Receives-FDA-Fast-Track-Designation-for-CLR-131-in-Lymphoplasmacytic-Lymphoma-Waldenstrom-s-Macroglobulinemia.html

[Sunofwolf]

CEO needs to be Fired,he done Zero except spend shareholders money on himself! Company is a fraud and its research a smoke screen. Doesn't deserve a penny, just go out of any business because nothing will ever happen here, except fake news release's and selling more stock.

[Crusader]

Before the well is poisoned more

by resident bears, consider this Seeking Alpha article about biotech companies capitalizing their developments. The story is NOT finished here even if short bears will not go away and stop saving us from ourselves.

Expected capital raises continue to ramp in healthcare amid pandemic
May 09, 2020 12:40 PM ETCheck-Cap Ltd. (CHEK)2 Comments
The need for capital continues apace for healthcare companies as they deal with COVID-19 disruptions.
Stock offerings:
Check-Cap (NASDAQ:CHEK): direct placement of 5M ordinary shares at $0.60 per share plus 5 1/2-year warrants to purchase up to 5M shares at $0.80. Friday's close was $0.54.
Cellectar Biosciences (NASDAQ:CLRB): $17.5M public offering of stock and five-year warrants.
Mixed shelf filings:
BioTelemetry (NASDAQ:BEAT): unspecified.
Clearside Biomedical (NASDAQ:CLSD): $250M.
Arcturus Therapeutics (NASDAQ:ARCT): $200M.
Mersana Therapeutics (NASDAQ:MRSN): $250M.

CLRB’s DILUTION IS HUNDREDS OF TIMES SMALLER THAN THOSE OTHERS LISTED.

The real issue is a cure; no the cost of getting there!

[Sunofwolf]

Worthless company.

[Sunofwolf]

This company's sells shares to pay for everything, including a fancy office in NJ for a fat CEO. Any one holding shares gets diluted stock. Any drug they claim they are working on is a scam! As is the entire briefcase company is. They use to make some products , now they have someone else claim to be making the drugs. This company is a Fraud.

[Sluicebox]

Love the simplicity of their drug, but still no financing in place ? Once they have financing in place I am a buyer

[Sunofwolf]

Ha Ha this junk is done!

[Sunofwolf]

Down a 100% from a fake high-this company has nothing of value at all. Investors only lose here.

[Sunofwolf]

Good go to nothing!

[Sunofwolf]

no one will even Mod this company anymore. Everyone lost dough and the CEO is sitting in NJ in a fancy office feet up on chair smoking and laughing at the sukers.

[Sunofwolf]

gov allows these phony companies to exist-Snake Oil.

[Sunofwolf]

100% cash-won't trade anything anymore to these crooks!